C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 211/78 (2006.01) A61K 31/17 (2006.01) A61K 31/4035 (2006.01) A61K 31/44 (2006.01) C07C 275/20 (2006.01) C07C 275/28 (2006.01)
Patent
CA 2549558
This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
Cette invention concerne l'utilisation d'un groupe de dérivés arylés de l'urée dans le traitement de maladies faisant intervenir Raf et des compositions pharmaceutiques servant à ce traitement.
Dumas Jacques
Khire Uday
Lowinger Timothy B.
Monahan Mary-Katherine
Natero Reina
Bayer Healthcare Llc
Corporation Bayer
Smart & Biggar
LandOfFree
Omega-carboxyaryl substituted diphenyl ureas as raf kinase... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Omega-carboxyaryl substituted diphenyl ureas as raf kinase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Omega-carboxyaryl substituted diphenyl ureas as raf kinase... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1750137